Cash Flow Statement
Growth Metrics

Mimedx (MDXG) EBITDA Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -932.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,003.00
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -2,673.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,673.00
Dec 31, 2025 264.00
Sep 30, 2025 3,001.00
Jun 30, 2025 2,695.00
Mar 31, 2025 2,515.00
Dec 31, 2024 937.00
Sep 30, 2024 1,498.00
Jun 30, 2024 2,749.00
Mar 31, 2024 2,701.00
Dec 31, 2023 4,131.00
Sep 30, 2023 2,871.00
Jun 30, 2023 2,425.00
Mar 31, 2023 2,179.00
Dec 31, 2022 2,159.00
Sep 30, 2022 -2,647.00
Jun 30, 2022 1,091.00
Mar 31, 2022 436.00
Dec 31, 2021 1,219.00
Sep 30, 2021 -213.00
Jun 30, 2021 -236.00
Mar 31, 2021 -1,496.00
Dec 31, 2020 -5,077.00
Sep 30, 2020 -2,562.00
Jun 30, 2020 -1,988.00
Mar 31, 2020 -3,125.00
Dec 31, 2019 628.00
Sep 30, 2019 868.00
Jun 30, 2019 -3,153.00
Mar 31, 2019 -2,290.00
Dec 31, 2018 -2,461.00
Sep 30, 2018 -1,327.00
Jun 30, 2018 -1,062.00
Mar 31, 2018 -689.00
Dec 31, 2017 1,554.00
Sep 30, 2017 -61.00
Jun 30, 2017 1,049.00
Mar 31, 2017 1,355.00
Dec 31, 2016 -481.00
Sep 30, 2016 889.00
Jun 30, 2016 1,172.00
Mar 31, 2016 471.00
Dec 31, 2015 2,421.00
Sep 30, 2015 5,939.00
Jun 30, 2015 1,478.00
Mar 31, 2015 2,745.00
Dec 31, 2014 10,418.00
Sep 30, 2014 8,791.00
Jun 30, 2014 12,371.00
Mar 31, 2014 30,751.00